RGRubén García-Cabrerizo

Rubén García-Cabrerizo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rubén García-Cabrerizo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterizing psilocybin as an antidepressant for adolescence in male and female rats

    by Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, M. Julia García-Fuster

    Adolescent depression is a significant public health concern, yet treatment options remain limited, particularly due to age- and sex-related differences in antidepressant efficacy. This study explored the rapid and long-lasting antidepressant-like potential of psilocybin in adolescent Sprague-Dawley rats, examining acute and repeated oral dosing effects while incorporating sex as a biological variable. An acute administration of psilocybin produced rapid antidepressant-like effects 30 minutes post-treatment in both male and female rats, demonstrated by reduced immobility and increased escape-related behaviour in the forced swim test. However, repeated daily administrations over 7 days revealed notable sex differences. In males, the antidepressant-like effects were sustained, at least, for up to 15 days post-treatment at both tested doses. In contrast, in females, the effects were dose-dependent and less enduring, persisting only up to 8 days at the highest dose tested. To the best of our knowledge, these results are the first ones to underscore psilocybin’s potential as a fast-acting and long-lasting antidepressant during adolescence, a developmental stage marked by high vulnerability to depression and reduced response to conventional treatments, while also emphasizing the importance of tailoring therapeutic approaches to individual biological factors such as sex.


  • Open Access

    Distinct Dendritic Morphological Changes in the Nucleus Accumbens of Microbiota-deficient Male Mice

    by Rubén García-Cabrerizo, Maria Francesca Viola, Pauline Luczynski, Gerard Clarke, John F. Cryan

    The gut microbiota has been shown to be an important regulator of brain and behaviour. Germ-free rodents are a key model to study the microbiome-gut-brain axis to reveal the microbial underpinnings of diseases, including those related to psychiatric illnesses. The present study evaluated whether the absence of gut microbiota could alter the morphological development of the nucleus accumbens, a brain region located in the ventral striatum involved in stress, mood and addiction. In germ-free mice, there was dendritic hypertrophy of medium spiny neurons in the shell and dendritic elongation in the core. This led to an increase in the number of stubby dendritic spines within the shell and an increase in both stubby and thin spines in the core. Taken together, these results indicate that the gut microbiota is essential for the normal development of the dendritic structure of medium spiny neurons in the nucleus accumbens and that altered remodelling may contribute to maladaptive psychiatric disorders.


  • Open Access

    EVALUATING THE CIRCADIAN MODULATION OF FADD AND RELATED MOLECULAR MARKERS IN DIFFERENT BRAIN REGIONS IN MALE RATS.

    by Fernando Yáñez-Gómez, Laura Gálvez-Melero, Sandra Ledesma-Corvi, Elena Hernández-Hernández, Cristian Bis-Humbert, Glòria Salort, Rubén García-Cabrerizo, María Julia García-Fuster

  • Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure

    by Cristian Bis-Humbert, Rubén García-Cabrerizo, M. Julia García-Fuster

    Background Further studies are needed to better understand the effects of potential novel antidepressants, such as cannabidiol, for the treatment of psychiatric disorders during adolescence. In this context, we evaluated in a rodent model of early-life stress (a single 24-h episode of maternal deprivation, PND 9), the antidepressant-like effects of adolescent cannabidiol alone and/or in combination with adolescent cocaine exposure (given the described beneficial effects of cannabidiol on reducing cocaine effects). Methods Maternally deprived Sprague-Dawley male rats were treated in adolescence with cannabidiol (with or without concomitant cocaine) and exposed to a battery of behavioral tests (forced-swim, novelty-suppressed feeding, open field, sucrose preference) across time. Putative enduring molecular correlates (CB receptors, BDNF) were evaluated in the hippocampus by western blot. Results Cannabidiol exerted antidepressant- and anxiolytic-like effects in rats exposed to early-life stress. Cocaine did not alter affective-like behavior during adolescence in rats exposed to early-life stress; however, a depressive- and anxiogenic-like phenotype emerged during adulthood, and cannabidiol exerted some behavioral improvements, along with the growing literature supporting its beneficial role for reducing cocaine intake and/or reinstatement in rodents. Finally, cannabidiol did not modulate hippocampal CB receptors or BDNF proteins, and although the data raised interesting questions about the possible role of CB1 receptors on modulating the long-term effects of cocaine, future research is needed to expand these findings. Conclusion Cannabidiol showed a promising therapeutic response in terms of ameliorating affect in a rat model of early-life stress during adolescence and up to adulthood.